Press Releases




Showing 1 - 15 of 579 between Jan 2004 and Sep 2020

The platform delivers educational information directly to mobile devices and simplifies the patient education process for healthcare systems, physicians and patients, ultimately improving outcomes

Free virtual institute and online community focuses on diagnosis and treatment of bladder cancer

Free online community focuses on bridging the gap in oral health and comprehensive dentistry

Clinical SolutionsElsevier launches COVID-19 Healthcare HubApr 16, 2020

Free resource aims to help clinicians around the world in combatting the on-going pandemic

New resource allows clinical researchers to capture clinical trial data in a secure environment, accelerating research and ultimately improving outcomes for patients

First taxonomy branch focuses on acupuncture, and will open up new resources to modern biomedical sciences as global interest in Traditional Chinese Medicine grows

Four-year KLAS Category Leader in Clinical Decision Support – Care Plans & Order Sets, “Care Planning” among solutions to be featured

Starting February 29, 2020, Elsevier will make clinical review articles and book chapters openly accessible for 60 days to raise awareness of rare diseases

Integration of GMDN data into Embase database offers critical data to global manufacturers ahead of new regulations

Elsevier’s global evidence-based solution recognized among the best in the marketplace, for the fourth year in a row

Online information center provides one-stop access to the latest medical and scientific information from across Elsevier’s journals and clinical resources

Leading experts from cancer centers, start-ups, technology, private equity, innovation centers, pharma and government will gather in Boston, March 29-31, 2020

Free virtual institute and online community focuses on diagnosis and treatment of advanced melanoma

Elsevier brought 12 medical student finalists from across the world to London to take part in a thrilling clinical knowledge challenge

New algorithm will allow drug developers to reduce risk and lower research and development costs